Dr. Hemangini Vora
Professor and Head of Cancer Biology & Immunohematology Lab

E-mail: hemanginivora@gcriindia.org


Qualification : MSc, PhD , Ph.D. Guiding Teacher
Designation : Professor and Head of Cancer Biology & Immunohematology Lab
Specialization : Cancer Research
Experience (in yrs.) : 37 years

Academic Achievements:

Awards & Achievements:
Dr. T.B. Patel Gold Medal awarded for Best Research Paper of 1992 entitled "Prolactin in advanced breast cancer An Indian experience" published in the journal "Breast Disease 1993".
Best Oral Paper presentation prize awarded for a research paper entitled "Ectopic production of prolactin in advanced tongue cancer" in the year 1993 by Indian Association of Endocrinologists
International Clinical Cytometry Society Travel Award to attend Course and Meeting of Clinical Cytometry Society, Portland, USA, October 9-15, 2008

Publication:

No. of publication 101 - (58 International/ 18 National/ 2 State/ 23 Institutional Journals)

Training/Fellowship:
Summer Program on Basics in Electrophoresis Techniques at Electrophoresis Institute, Biotech-Yercaud, Yercaud, May 5-14, 2004.
National Meeting on Guidelines for Immunophenotyping of Haematolymphoid Neoplasms and Workshop on analysis of Flowcytometric Data at Tata Memorial Hospital, Mumbai, March 13-15, 2008.
International Clinical Cytometry Society Travel Award to attend Course and Meeting of Clinical Cytometry Society, Portland, USA, October 9-15, 2008.
Workshop on Advanced Clinical Applications of Flowcytometry organized by National Institute of Immunohematology, February 23-26, 2010.

Area of Interest:
The main areas of research include development of cost effective protein panel by CGH array and transcriptome sequencing for identification of novel targets for therapeutic intervention and better prognosticators in triple negative breast cancer. Role of tumor microenvironment in the development of tumor progression, metastasis and therapeutic resistance in breast and oral cancers. Molecular analysis and MRD detection in acute leukemias.